| Symbol |
Name |
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
AR
|
androgen receptor
|
|
ATF2
|
activating transcription factor 2
|
|
ATM
|
ATM serine/threonine kinase
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCND2
|
cyclin D2
|
|
CD247
|
CD247 molecule
|
|
CD28
|
CD28 molecule
|
|
CD3EAP
|
CD3e molecule, epsilon associated protein
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD5
|
CD5 molecule
|
|
CDC25A
|
cell division cycle 25A
|
|
CDH5
|
cadherin 5, type 2 (vascular endothelium)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEBPE
|
CCAAT/enhancer binding protein (C/EBP), epsilon
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHN2
|
chimerin 2
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CREB1
|
cAMP responsive element binding protein 1
|
|
CRKL
|
v-crk avian sarcoma virus CT10 oncogene homolog-like
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2RB
|
colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage)
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
CSRP2
|
cysteine and glycine-rich protein 2
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTTN
|
cortactin
|
|
DAPK3
|
death-associated protein kinase 3
|
|
DCP1A
|
decapping mRNA 1A
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DOK2
|
docking protein 2, 56kDa
|
|
DUSP3
|
dual specificity phosphatase 3
|
|
EIF4B
|
eukaryotic translation initiation factor 4B
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1
|
|
EPOR
|
erythropoietin receptor
|
|
EZR
|
ezrin
|
|
FLII
|
flightless I homolog (Drosophila)
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FYB
|
FYN binding protein
|
|
G3BP1
|
GTPase activating protein (SH3 domain) binding protein 1
|
|
GAB1
|
GRB2-associated binding protein 1
|
|
GAB2
|
GRB2-associated binding protein 2
|
|
GATA1
|
GATA binding protein 1 (globin transcription factor 1)
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B
|
|
GSK3A
|
glycogen synthase kinase 3 alpha
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
H3F3A
|
H3 histone, family 3A
|
|
H3F3B
|
H3 histone, family 3B (H3.3B)
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HCLS1
|
hematopoietic cell-specific Lyn substrate 1
|
|
HIST1H3A
|
histone cluster 1, H3a
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSH2D
|
hematopoietic SH2 domain containing
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKBKG
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL33R
|
interleukin 33 receptor
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IL7R
|
interleukin 7 receptor
|
|
IL9R
|
interleukin 9 receptor
|
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa
|
|
IRAK1
|
interleukin-1 receptor-associated kinase 1
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRS1
|
insulin receptor substrate 1
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB4
|
integrin, beta 4
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
KLF10
|
Kruppel-like factor 10
|
|
LAT
|
linker for activation of T cells
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin)
|
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)
|
|
LEPR
|
leptin receptor
|
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
LIMK1
|
LIM domain kinase 1
|
|
LIMK2
|
LIM domain kinase 2
|
|
LPXN
|
leupaxin
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K4
|
mitogen-activated protein kinase kinase 4
|
|
MAP3K2
|
mitogen-activated protein kinase kinase kinase 2
|
|
MAP3K3
|
mitogen-activated protein kinase kinase kinase 3
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPK9
|
mitogen-activated protein kinase 9
|
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3
|
|
MAZ
|
MYC-associated zinc finger protein (purine-binding transcription factor)
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MPL
|
MPL proto-oncogene, thrombopoietin receptor
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
NBN
|
nibrin
|
|
NCOA1
|
nuclear receptor coactivator 1
|
|
NDRG1
|
N-myc downstream regulated 1
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIB
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NR2F6
|
nuclear receptor subfamily 2, group F, member 6
|
|
OSMR
|
oncostatin M receptor
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PELI1
|
pellino E3 ubiquitin protein ligase 1
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
POLR2A
|
polymerase (RNA) II (DNA directed) polypeptide A, 220kDa
|
|
PPP1CA
|
protein phosphatase 1, catalytic subunit, alpha isozyme
|
|
PPP2CA
|
protein phosphatase 2, catalytic subunit, alpha isozyme
|
|
PRKAA1
|
protein kinase, AMP-activated, alpha 1 catalytic subunit
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRKCA
|
protein kinase C, alpha
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRKRA
|
protein kinase, interferon-inducible double stranded RNA dependent activator
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTK2B
|
protein tyrosine kinase 2 beta
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7
|
|
PXN
|
paxillin
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RB1
|
retinoblastoma 1
|
|
RBM4
|
RNA binding motif protein 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RXRA
|
retinoid X receptor, alpha
|
|
SET
|
SET nuclear proto-oncogene
|
|
SGK1
|
serum/glucocorticoid regulated kinase 1
|
|
SH3BP2
|
SH3-domain binding protein 2
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRPA
|
signal-regulatory protein alpha
|
|
SKAP1
|
src kinase associated phosphoprotein 1
|
|
SLC10A2
|
solute carrier family 10 (sodium/bile acid cotransporter), member 2
|
|
SLC9A1
|
solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1
|
|
SMAD2
|
SMAD family member 2
|
|
SP1
|
Sp1 transcription factor
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SRF
|
serum response factor (c-fos serum response element-binding transcription factor)
|
|
STAP2
|
signal transducing adaptor family member 2
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT2
|
signal transducer and activator of transcription 2, 113kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STK17B
|
serine/threonine kinase 17b
|
|
SYK
|
spleen tyrosine kinase
|
|
SYTL1
|
synaptotagmin-like 1
|
|
TAB1
|
TGF-beta activated kinase 1/MAP3K7 binding protein 1
|
|
TAB2
|
TGF-beta activated kinase 1/MAP3K7 binding protein 2
|
|
TAB3
|
TGF-beta activated kinase 1/MAP3K7 binding protein 3
|
|
TAX1BP1
|
Tax1 (human T-cell leukemia virus type I) binding protein 1
|
|
TBX21
|
T-box 21
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TLR5
|
toll-like receptor 5
|
|
TNFAIP1
|
tumor necrosis factor, alpha-induced protein 1 (endothelial)
|
|
TNK2
|
tyrosine kinase, non-receptor, 2
|
|
TP53
|
tumor protein p53
|
|
TRAF3IP2
|
TRAF3 interacting protein 2
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
ULK1
|
unc-51 like autophagy activating kinase 1
|
|
VIM
|
vimentin
|
|
WIPF1
|
WAS/WASL interacting protein family, member 1
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZC3H12A
|
zinc finger CCCH-type containing 12A
|
